FIELD: pharmaceutics.
SUBSTANCE: group of inventions refers to a pharmacological treatment of bacterial infectious diseases in humans. Use of apramycin is disclosed or apramycin derivatives to treat bacterial infectious diseases in humans; its use for preparing a drug for treating bacterial infectious diseases in a human and a method of treating thereof.
EFFECT: it is demonstrated that apramycin surprisingly does not have the expected high level of toxicity observed with related aminoglycoside antibiotics, in particular, it has low risk of cochleatoxicity and nephrotoxicity, that makes it applicable in medicine for treating a human; besides, effectiveness of apramycin in vitro against tuberculosis and non-tuberculous mycobacteria strains is shown.
10 cl, 10 tbl, 12 ex, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| WATER-SOLUBLE ANALOGUES CC-1065 AND THEIR CONJUGATES | 2007 |
|
RU2489423C2 |
| ANTHRACYCLINE GLYCOSIDES AND THEIR PHARMACEUTICALLY ACCEPTABLE ACID-ADDITIVE SALTS, METHOD OF THEIR SYNTHESIS, DIIODOINTERMEDIATE COMPOUND AND METHOD OF ITS SYNTHESIS | 1991 |
|
RU2100366C1 |
| MALEOPIMARIC ACID METHYL ESTER IMIDOAMINE BIS-ADDUCTS WITH AZAPOLYCYCLIC SPACERS AND METHOD FOR THEIR PREPARATION | 2022 |
|
RU2792569C1 |
| PROLYL HYDROXYLASE INHIBITORS AND APPLICATION METHODS THEREOF | 2007 |
|
RU2429226C9 |
| TRICYCLIC PYRROLE DERIVATIVES, METHOD FOR PRODUCTION THEREOF AND USE THEREOF AS KINASE INHIBITORS | 2012 |
|
RU2591191C2 |
| NEW EFFECTIVE AMINOGLYCOSIDE ANTIBIOTIC AGAINST MULTIDRUG-RESISTANT BACTERIA | 2016 |
|
RU2751634C2 |
| DERIVATIVES OF ANTHRACYCLINONE AND THEIR USE IN AMYLOIDOSIS | 1995 |
|
RU2167661C2 |
| METHOD FOR MANUFACTURING OF TERPENOID DIMER WITH PERHYDROTETRACENE SPACER AND ITS USE AS WITH A CYTOTOXIC ACTIVITY | 2023 |
|
RU2794745C1 |
| AMIDE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS | 2005 |
|
RU2401259C2 |
| METHOD FOR MANUFACTURING OF IMIDOAMINE BIS-ADDUCT OF MALEOPIMARIC ACID METIL ESTER WITH DIMETHYL-HEXAAZAPERHYDROPYRENE SPACER AND ITS USE AS A DRUG WITH CYTOTOXIC ACTIVITY | 2023 |
|
RU2794743C1 |
